FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING C3 DELIVERY SYSTEM

MDR report key: 2142918 · Received June 22, 2011

Report

Report Number
2017233-2011-00300
Event Type
Injury
Date Received
June 22, 2011
Date of Event
April 21, 2011
Report Date
June 21, 2011
Manufacturer
W.L. GORE & ASSOCIATES, INC.
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6), 2011, THIS PT UNDERWENT TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM WITH GORE EXCLUDER AAA ENDOPROSTHESES. IT WAS REPORTED THAT A TRUNK-IPSILATERAL LEG COMPONENT FEATURING C3 DELIVERY SYSTEM MOVED 8 MM DISTAL TO THE LOWEST RENAL ARTERY DURING DEPLOYMENT DUE TO SEVERE PROXIMAL NECK ANGLE AND TORTUOSITY. THE PHYSICIAN ATTEMPTED TO RECONSTRAIN THE DEVICE FOR REPOSITIONING, BUT THE DEVICE WOULD NOT ADVANCE DUE TO THE ANGULATION AND TORTUOSITY. IT WAS REPORTED THE PHYSICIAN DID NOT WANT TO FORCE THE DEVICE INTO PLACEMENT, SO HE ELECTED TO LEAVE THE DEVICE 8 MM FROM THE INTENDED POSITION. FINAL ANGIOGRAPHY SHOWED A PROXIMAL TYPE I ENDOLEAK; HOWEVER, THE PHYSICIAN REPORTEDLY ELECTED TO LEAVE THE ENDOLEAK AND MONITOR THE PT. THE PT TOLERATED THE PROCEDURE. IT WAS REPORTED THAT THE ENDOLEAK DID NOT RESOLVE; HOWEVER, NO ANEURYSM ENLARGEMENT WAS IDENTIFIED. ON (B)(6), 2011, AN ADD'L PROCEDURE WAS PERFORMED TO TREAT THE PERSISTENT PROXIMAL TYPE I ENDOLEAK. THE PHYSICIAN PLACED AN AORTIC EXTENDER COMPONENT FOR PROXIMAL EXTENSION, AND FINAL ANGIOGRAPHY SHOWED RESOLUTION OF THE ENDOLEAK. THE PT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING C3 DELIVERY SYSTEM MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES, INC. WLG425 8365282

Patients

Seq Age Sex Outcome Treatment
1 86 YR Hospitalization| R FLOMAX| SIMVASTATIN| METOPROLOL| FOSSAMAX| ASPIRIN